CureBay raises Rs 100 crore, led by IvyCap, for rural AI clinics

CureBay, an Indian health-technology start-up that runs clinics in rural areas, has raised about Rs 100 crore (roughly $10.6 million) in a pre-Series C funding round led by IvyCap Ventures, according to reports published on Thursday, October 22, 2026. The round is made up of about Rs 69 crore in equity from IvyCap and existing investors, and more than Rs 30 crore in debt from Trifecta Capital, Alteria Capital and VentureSoul Partners. The company says it will use the money to expand into more regions, strengthen its delivery network and invest in its artificial intelligence (AI) tools.

Most of India's doctors, hospitals and diagnostic laboratories are in cities, while a large share of the population lives in villages and small towns. For many rural families, seeing a specialist means a long and costly trip. CureBay's model tries to close part of that gap with technology. A local health worker in a village clinic helps the patient connect to a doctor by video, arranges tests, orders medicines and, when needed, helps with admission to a partner hospital. The company began in Odisha and has spread to other states.

AI enters the picture in two ways. First, as screening: software that looks at a photo of the skin or teeth, or at a blood reading, and flags who may need a doctor's attention. Second, as support for the clinic staff, such as tools that help doctors sort cases by urgency. These are the company's descriptions of its products. AI screening can help where specialists are scarce, but it is meant to assist a trained clinician, not replace one, and its accuracy depends on how well it has been tested on the people it is used on.

The structure of the round is also worth noting. Venture debt is a loan given to young companies by specialist lenders, usually alongside equity. It lets founders raise money without giving away as much ownership, but it must be repaid. A start-up that takes nearly a third of a round as debt is signalling confidence that its revenue can service the loan, which fits the company's claim of strong recurring revenue.

For the wider start-up ecosystem, the deal is a sign that investors are still backing health-tech businesses that combine physical clinics with software, a model that is slower and costlier to grow than a pure app but harder for rivals to copy.

Short-term: CureBay plans to open clinics in new areas, including Andhra Pradesh, hire and train more local health workers and add AI screening tools.

Long-term: If the model works at scale, more rural patients could get a first consultation and basic tests close to home, and investors may put more money into "phygital" health businesses, which mix physical clinics with digital services.

Who is affected: Rural patients in the states where CureBay operates, local health workers employed as Swasthya Mitras, partner hospitals and laboratories, CureBay's investors and lenders, and other health-tech start-ups competing for the same funding.

Questions and Answers